This is to inform you that a meeting of the Board of Directors of AstraZeneca Pharma India Limited will be held on Monday, November 6, 2017 inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2017.<BR> <BR> We would also like to inform you that the 'Trading Window' shall remain closed for all Designated Persons, from September 16, 2017 to November 8, 2017 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.<BR>
|